Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely. J. Hepatol. 2013, 58, 676–683. [CrossRef] [PubMed] 21. Lai, C.L.; Wong, D.; Ip, P.; Kopaniszen, M.; Seto, W.K.;...
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely. J. Hepatol. 2013, 58, 676–683. [CrossRef] [PubMed] 21. Lai, C.L.; Wong, D.; Ip, P.; Kopaniszen, M.; Seto, W.K.; Fung, J.; Huang, F.Y....